The UCCRC Senior Leadership consists of the Director, two Co-Deputy Directors, and 7 Associate Directors. The composition and structure of this team has changed over the past five years, reflecting UCCRC planning and evaluation activities, new initiatives and approaches at the level of the Biological Sciences Division (BSD), new recruitments, and new UCCRC strategic initiatives and overall goals. In April 2004, Dr. Le Beau succeeded Dr. Vogelzang as UCCRC Director. To facilitate translational research, as well as to optimize integration of both clinical and basic research, Dr. Le Beau appointed two Deputy Directors: Dr. Marsha Rosner, the Charles B. Muggins Professor, Chair of the Ben May Department for Cancer Research and an experienced basic researcher, and Dr. Everett Vokes, the John E. Ultmann Professor and Director of the Section of Hematology/Oncology, PI of the NCI Phase II contract and an experienced clinical researcher. Both Drs. Rosner and Vokes have previously held senior leadership roles within the UCCRC. Dr. Marcy List continues in her role as Associate Director for Administration, and her responsibilities have been expanded. Drs. Greene and Ratain continue in their roles as Associate Director for Basic Sciences, Education and Training, and Associate Director for Clinical Sciences, respectively. To expand our efforts in cancer epidemiology, prevention, and control, we recruited Habibul Ahsan, MD, who assumed the position of UCCRC Associate Director for Population Research in December 2006. To facilitate the enhancement of community outreach programs and recruitment of minorities to clinical trials, as well as to expand our research portfolio in health disparities, Rick Kittles, PhD, was recruited in August 2006 and has assumed the newly-created position of UCCRC Associate Director for Diversity and Community Outreach. Recognizing the need to upgrade informatics activities in support of UCCRC researchers and to train faculty and staff in the use of existing technologies, Yves Lussier, MD, recruited in Jan 2006, was appointed UCCRC Associate Director for Biomedical Informatics. Finally, to oversee and integrate UCCRC core facilities with those of the BSD, Julie Auger, BS, Director of the BSD Office of Shared Research Facilities was appointed UCCRC Associate Director for Core Facilities. The above individuals are members of the Cancer Advisory Committee (CAC), which also includes additional leaders of academic units engaged in cancer research and care of patients with cancer, e.g., Radiation Oncology, Surgical Oncology, and Pediatric Oncology. The CAC oversees all UCCRC activities, including strategic planning, programmatic development, development of shared resources, recruitment, and oversight of the pilot project program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-37
Application #
8375689
Study Section
Special Emphasis Panel (ZCA1-RTRB-N)
Project Start
Project End
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
37
Fiscal Year
2012
Total Cost
$295,875
Indirect Cost
$103,429
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Zeng, Zongyue; Huang, Bo; Huang, Shifeng et al. (2018) The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis 5:62-74
Lee, Ji-Hye; Park, Beom Seok; Han, Kang R et al. (2018) Insight Into the Interaction Between RNA Polymerase and VPg for Murine Norovirus Replication. Front Microbiol 9:1466
Cheng, Jason X; Chen, Li; Li, Yuan et al. (2018) RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun 9:1163
Johnson, Marianna B; Hoffmann, Joscelyn N; You, Hannah M et al. (2018) Psychosocial Stress Exposure Disrupts Mammary Gland Development. J Mammary Gland Biol Neoplasia 23:59-73
Sweis, Randy F; Zha, Yuanyuan; Pass, Lomax et al. (2018) Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer. J Immunother Cancer 6:24
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966

Showing the most recent 10 out of 668 publications